Is Overall Sentiment on Agilent Technologies Bearish?

After this afternoon's -2.3% drop to $132.76 per share, Agilent Technologies might just keep moving past its target price of $137.81. With an average analyst rating of buy, and target prices from $119.0 to $165.0, the stock's next move is anyone's guess.

Agilent Technologies's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.61. The company's insiders own 0.29% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 90.4%. In conclusion, we believe there is mixed market sentiment regarding Agilent Technologies.

Institutions Invested in Agilent Technologies

Date Reported Holder Percentage Shares Value
2023-09-30 Blackrock Inc. 10% 28,015,368 $3,719,460,315
2023-09-30 Vanguard Group Inc 9% 25,072,252 $3,328,717,521
2023-09-30 State Street Corporation 4% 12,629,168 $1,676,711,481
2023-09-30 Massachusetts Financial Services Co. 4% 11,076,270 $1,470,540,979
2023-09-30 Wellington Management Group, LLP 4% 10,255,526 $1,361,574,903
2023-09-30 T. Rowe Price Investment Management, Inc. 3% 10,122,358 $1,343,894,853
2023-09-30 Price (T.Rowe) Associates Inc 3% 7,385,815 $980,577,723
2023-09-30 Pictet Asset Management Holding SA 2% 6,846,232 $908,939,987
2023-09-30 Geode Capital Management, LLC 2% 6,496,796 $862,547,116
2023-09-30 Morgan Stanley 1% 4,292,200 $569,853,930
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.